A FAERS analysis showed odds of death or hospitalization are higher when lamotrigine-linked HLH with organ failure occurs without a rash.

Four years ago, after entering what is known as menopause, I began to suffer from asteatotic eczema caused by dryness every ...

Roivant's brepocitinib (Lisraya) succeeded in two non-infectious uveitis trials, with plans to file for approval in H1 2027.

The approval only covers a narrow group of rectal cancer patients, but for them it may rewrite what treatment looks like.

Identify R&D opportunities through pipeline benchmarking, clinical-stage analysis, unmet needs, collaborations, licensing, mergers and acquisitions.Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Atopic ...

It seems we cannot go a week without hearing about some new health or beauty craze, usually on social media sites that cater ...

GSK received U.S. Food and Drug Administration (FDA) approval for Jemperli (dostarlimab) as the first and only immunotherapy for adults with stage II and III microsatellite instability-high ...

A retrospective study of 313 patients found that baseline renal impairment doubled the risk of rash during gemcitabine plus ...

A Japanese case series confirms rocuronium bromide as the cause of anaphylactic shock in four surgical patients, revealing ...

It took 103rd Precinct Commander Genienne King a little over 10 minutes of talking at a Precinct Community Council meeting on ...

For those in a hurry—a concise version summarizing only the main points is available on the blog.A rash that appeared after ...

Biogen's experimental drug litifilimab shows significant improvement in skin symptoms of cutaneous lupus erythematosus, with 27.2% of patients achieving clear skin after one year, amid challenges in ...